Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.
Fiche publication
Date publication
septembre 2015
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NGUYEN Philippe
Tous les auteurs :
Verna EC, Patel J, Bettencourt R, Nguyen P, Hernandez C, Valasek MA, Kisselva T, Brenner DA, Loomba R
Lien Pubmed
Résumé
Pentraxin-2 (PTX-2), a serum protein, inhibits inflammation and fibrosis, and recombinant PTX-2 is being tested as an anti-fibrotic agent.
Mots clés
Adult, Aged, Biomarkers, Blood Proteins, metabolism, Cross-Sectional Studies, Female, Humans, Liver Cirrhosis, blood, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, blood, Severity of Illness Index
Référence
Aliment. Pharmacol. Ther.. 2015 Sep;42(5):582-90